Autologous Pluripotent Stem Cell-Derived β-Like Cells for Diabetes Cellular Therapy

Diabetes
Jeffrey R Millman, Felicia W Pagliuca

Abstract

Development of stem cell technologies for cell replacement therapy has progressed rapidly in recent years. Diabetes has long been seen as one of the first applications for stem cell-derived cells because of the loss of only a single cell type-the insulin-producing β-cell. Recent reports have detailed strategies that overcome prior hurdles to generate functional β-like cells from human pluripotent stem cells in vitro, including from human induced pluripotent stem cells (hiPSCs). Even with this accomplishment, addressing immunological barriers to transplantation remains a major challenge for the field. The development of clinically relevant hiPSC derivation methods from patients and demonstration that these cells can be differentiated into β-like cells presents a new opportunity to treat diabetes without immunosuppression or immunoprotective encapsulation or with only targeted protection from autoimmunity. This review focuses on the current status in generating and transplanting autologous β-cells for diabetes cell therapy, highlighting the unique advantages and challenges of this approach.

References

Jun 10, 1993·The New England Journal of Medicine·D M Nathan
Nov 6, 1998·Science·J A ThomsonJ M Jones
Nov 1, 2005·Nature Biotechnology·Kevin A D'AmourEmmanuel E Baetge
Oct 20, 2006·The New England Journal of Medicine·Dina Gould Halme, David A Kessler
Oct 21, 2006·Nature Biotechnology·Kevin A D'AmourEmmanuel E Baetge
Nov 11, 2008·The British Journal of Surgery·S MeraniA M J Shapiro
Sep 2, 2009·Proceedings of the National Academy of Sciences of the United States of America·René MaehrDouglas A Melton
May 17, 2011·Nature·Tongbiao ZhaoYang Xu
Dec 1, 2012·Stem Cells Translational Medicine·Yogish C KudvaYasuhiro Ikeda
Jan 12, 2013·The Journal of Biological Chemistry·Adrian K K TeoRohit N Kulkarni
May 1, 2013·Molecular Therapy : the Journal of the American Society of Gene Therapy·Laura RiolobosDavid W Russell
May 30, 2013·Development·Felicia W Pagliuca, Douglas A Melton
Aug 7, 2013·Advanced Drug Delivery Reviews·David W Scharp, Piero Marchetti
Dec 21, 2013·Diabetes Care·UNKNOWN American Diabetes Association
Feb 12, 2014·Proceedings of the National Academy of Sciences of the United States of America·Sinisa HrvatinDouglas A Melton
Mar 4, 2014·Advanced Drug Delivery Reviews·Clark K Colton
Sep 12, 2014·Nature Biotechnology·Alireza RezaniaTimothy J Kieffer
Oct 11, 2014·Cell·Felicia W PagliucaDouglas A Melton
Dec 2, 2014·Nature Biotechnology·Thorsten M SchlaegerGeorge Q Daley
Jul 15, 2015·Expert Opinion on Biological Therapy·Alice Anna TomeiCamillo Ricordi
Sep 29, 2015·Stem Cell Reports·Behnam Ahmadian BaghbaderaniMahendra S Rao
Oct 30, 2015·Scientific Reports·Alizée J GrimmJeffrey A Hubbell
Nov 21, 2015·Stem Cell Reports·Sara E HowdenJames A Thomson
Nov 27, 2015·Science Translational Medicine·Jeffrey A BluestoneQizhi Tang
Jan 7, 2016·Nature Communications·Saiyong ZhuSheng Ding

❮ Previous
Next ❯

Citations

Jun 26, 2018·Diabetes·Ruth A Singer, Lori Sussel
Mar 15, 2019·Circulation Research·Thomas Eschenhagen, Florian Weinberger
May 14, 2019·Journal of Cellular Biochemistry·Roozbeh Akbari MotlaghSeyed Mohammad Gheibi Hayat
Sep 10, 2019·Advanced Materials·Amanda L FacklamDaniel G Anderson
Apr 22, 2020·Biotechnology and Bioengineering·Nooshin AminiSusan T Sharfstein
Jun 13, 2019·Journal of the Endocrine Society·Wendy M McKimpson, Domenico Accili
Feb 26, 2020·Nature Biotechnology·Nathaniel J HogrebeJeffrey R Millman
May 10, 2020·Biomedicines·Elisabetta Donzelli, Arianna Scuteri
Apr 24, 2020·Science Translational Medicine·Kristina G MaxwellJeffrey R Millman
Apr 11, 2020·Tissue Engineering. Part B, Reviews·Jianrui Ma, Chengyang Huang
Sep 11, 2020·Tissue Engineering. Part B, Reviews·Rachel E GurlinEsther Latres
Feb 23, 2020·Cell Death & Disease·Julie K BrayThomas D Schmittgen
Jul 3, 2020·Nature Reviews. Drug Discovery·Erin A Kimbrel, Robert Lanza
Jan 25, 2020·Nature Biomedical Engineering·Ulrich BlacheEileen Gentleman
Aug 1, 2020·Frontiers in Bioengineering and Biotechnology·Leonardo Velazco-CruzJeffrey R Millman
Dec 2, 2020·Biomedicines·Shoichiro Sumi
Feb 19, 2021·Genes to Cells : Devoted to Molecular & Cellular Mechanisms·Niloufer P DumasiaPrasad S Pethe
Jan 9, 2021·The Journal of Clinical Endocrinology and Metabolism·Silvia PellegriniLorenzo Piemonti
Apr 3, 2021·Journal of Translational Medicine·Ammira Al-Shabeeb AkilKhalid A Fakhro
Apr 6, 2021·Synthetic Biology·Mingqi XieMartin Fussenegger
May 6, 2021·Cell Reports Medicine·Kristina G Maxwell, Jeffrey R Millman
Jun 10, 2021·Experimental Cell Research·Javad HashemiParvin Pasalar
Aug 6, 2021·Nature Protocols·Nathaniel J HogrebeJeffrey R Millman
Apr 13, 2021·Endocrine Reviews·John T WalkerAlvin C Powers
Nov 3, 2021·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Araceli Rivera-OrdazLorenza Lazzari

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Autoimmune Disease Therapy

In autoimmune diseases, the immune system responds and attacks self-antigens and damages or impairs the function of the tissues. The treatment for autoimmune diseases often involves immunosuppressive agents, but newer treatments are being investigated. Discover the latest research on autoimmune disease therapy here.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

American Diabetes Association Journals

Discover the latest diabetes research published by the journals from the American Diabetes Association.

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

© 2022 Meta ULC. All rights reserved